Kilambi News
Wednesday, November 18, 2026

White House pulls Overton nomination to lead FDA

Life Sciences Tuesday, November 17, 2026 - Updated Nov 17, 2026 20:24

The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration, a day before a Senate committee vote, amid indications she lacked the votes for confirmation.

Why it matters: The withdrawal leaves the FDA under acting leadership since May and extends a run of failed Trump health nominations, with Republicans racing to confirm nominees before Democrats take the Senate in January.

Data as of Associated Press report of November 17, 2026, read in full in this run via the Tri-City Record's AP publication; the withdrawal was also reported the same day by STAT and Endpoints News in this site's feed queue. Developing item.

The White House said on Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration, amid growing indications she did not have the votes to win Senate confirmation, the Associated Press reported. Overton, a physician and White House domestic policy adviser nominated in August, faced bipartisan questions about her willingness to break from President Trump, particularly on his unsupported claims about the dangers of childhood vaccines, and Senate health committee chair Bill Cassidy said earlier in the day he remained undecided ahead of a committee vote scheduled for Wednesday.

Overton would have needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee, where Democrats hold 11 seats. The FDA has been led on an acting basis by Kyle Diamantas since Dr. Marty Makary stepped down in May, and the withdrawal follows earlier pulled Trump health nominations, including his first CDC pick and two surgeon general nominees.

Sources

  1. White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans - Associated Press, via Tri-City Record - 2026-11-17
  2. STAT+: White House pulls nomination of Heidi Overton to lead FDA - STAT - 2026-11-17